Hereon Pharmaceuticals, LLC

Form 483 issued April 5, 2019 · Emigsville, Pennsylvania

Inspection
Apr 1 – Apr 5, 2019
Investigator
Mindy M. Chou
Observations
3
Pages
2
FEI number
2522638

In short: On April 5, 2019, FDA issued a Form 483 with 3 observations to Hereon Pharmaceuticals, LLC in Emigsville, Pennsylvania (FEI 2522638) after an inspection that ran Apr 1 – Apr 5, 2019. The investigator was Mindy M. Chou. Most observations concern quality system and laboratory controls.

At a glance

Quality system and laboratory controls account for 2 of 3 observations.

Quality system1
Laboratory controls1
Facilities & equipment1

What FDA observed

Preview: the opening words of each observation
  1. 01

    There is a failure to thoroughly review the failure of a batch or any of its…

  2. 02

    The use of instruments not meeting…

  3. 03

    Routine calibration of mechanical equipment is not performed according to a written program designed…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Hereon Pharmaceuticals, LLC?

FDA listed 3 observations on this Form 483, mostly about quality system, laboratory controls and facilities & equipment. The opening words of each observation are shown on this page.

Who inspected Hereon Pharmaceuticals, LLC?

Mindy M. Chou is named on this Form 483, for the inspection of Apr 1 – Apr 5, 2019. Each investigator has a profile showing what they cite most.

When was Hereon Pharmaceuticals, LLC inspected by FDA?

The inspection ran Apr 1 – Apr 5, 2019, and the Form 483 is dated April 5, 2019.

How do I get the full Form 483 for Hereon Pharmaceuticals, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free